Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis
Treatment of tuberculosis needs to be taken for several weeks, despite good potency of drugs in vitro. Here, the authors show that mesenchymal stem cells can harbor Mycobacterium tuberculosis providing a niche for evasion of anti-bacterial drugs and cytokines.
Guardado en:
Autores principales: | Neharika Jain, Haroon Kalam, Lakshyaveer Singh, Vartika Sharma, Saurabh Kedia, Prasenjit Das, Vineet Ahuja, Dhiraj Kumar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b275098bf93142e3b839d17de3f790ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease
por: Manasvini Markandey, et al.
Publicado: (2021) -
Pennsylvania Charter of Privileges
Publicado: (2017) -
Murine models for studying immunopathogenesis in gastrointestinal lesions: How to go about it
por: Neharika Jain, et al.
Publicado: (2021) -
Privileges & Prerogatives Granted to Columbus
Publicado: (2017) -
To serve patients is our greatest privilege
por: David Feinberg
Publicado: (2014)